Stocktoria
Mineralys Therapeutics, Inc. MLYS
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2023-02-10
Mineralys Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 1,252,958 | $33.8M | 1.54% |
| BlackRock Finance, Inc. | 2,045,702 | $23.9M | 2.51% |
| CITADEL ADVISORS LLC | 595,998 | $16.1M | 0.73% |
| RENAISSANCE TECHNOLOGIES LLC | 378,300 | $10.2M | 0.46% |
| D. E. Shaw & Co., Inc. | 352,729 | $9.5M | 0.43% |
| TWO SIGMA INVESTMENTS, LP | 162,082 | $4.4M | 0.2% |
| AQR CAPITAL MANAGEMENT LLC | 152,504 | $4.1M | 0.19% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.